Copy to clipboard 
Amnovis and BAAT Medical have set up a partnership to jointly offer an innovative, fast-turnaround process for 3D-printed medical devices. Both companies jointly span the complete process, from initial design idea over medical engineering to legal manufactured devices ready for use.
BAAT Medical has pioneered the engineering and development of 3D-printed spinal fusion implants, resulting in multiple CE Marks and FDA clearances and more than 50,000 implants manufactured to date. Amnovis’ founders were among the first to employ L-PFB for printing titanium medical devices, such as orthopedic and spinal implants.
The collaboration is intended to offer a more comprehensive view on ways to optimally tune design and development as well as material selection and manufacturing in the context of specific AM medical device applications. Both companies work on a joint technology and application roadmap and actively validate new AM technologies to set new standards for specific medical device types. They align these efforts with the business potential and time to market of new AM technologies in the medical sector. As part of this effort, they drill down deeper on AM materials and post-processing methods as well as process automation and validation.
Ruben Wauthle, CEO and Co-founder of Amnovis, said, “We see great potential in jointly innovating various AM medical device applications. We know each other for years, share the same innovative drive, and collaborate intensively to better align design and development with material selection and manufacturing. At Amnovis, we rely on our comprehensive AM workflow and production platform, which is entirely ISO 13485:2016 certified. Digital process automation enables us to provide full traceability and repeatability to flexibly scale up manufacturing of standard and patient-specific AM medical devices.”
Gert Nijenbanning, Managing Director of BAAT Medical, said, “We believe that efficiency in development and production throughout the whole chain is essential to keep investments in innovations of medical devices feasible, especially for European markets where the MDR is a reality. Together we want to build on the complementary expertise of Amnovis and BAAT Medical to collaborate and take 3D printing of medical devices to the next level.”
Source: Amnovis and BAAT Medical
